These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 35495127)

  • 81. Complementary activities of DOT1L and Menin inhibitors in MLL-rearranged leukemia.
    Dafflon C; Craig VJ; Méreau H; Gräsel J; Schacher Engstler B; Hoffman G; Nigsch F; Gaulis S; Barys L; Ito M; Aguadé-Gorgorió J; Bornhauser B; Bourquin JP; Proske A; Stork-Fux C; Murakami M; Sellers WR; Hofmann F; Schwaller J; Tiedt R
    Leukemia; 2017 Jun; 31(6):1269-1277. PubMed ID: 27840424
    [TBL] [Abstract][Full Text] [Related]  

  • 82. DOT1L O-GlcNAcylation promotes its protein stability and MLL-fusion leukemia cell proliferation.
    Song T; Zou Q; Yan Y; Lv S; Li N; Zhao X; Ma X; Liu H; Tang B; Sun L
    Cell Rep; 2021 Sep; 36(12):109739. PubMed ID: 34551297
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Discovery of Novel Dot1L Inhibitors through a Structure-Based Fragmentation Approach.
    Chen C; Zhu H; Stauffer F; Caravatti G; Vollmer S; Machauer R; Holzer P; Möbitz H; Scheufler C; Klumpp M; Tiedt R; Beyer KS; Calkins K; Guthy D; Kiffe M; Zhang J; Gaul C
    ACS Med Chem Lett; 2016 Aug; 7(8):735-40. PubMed ID: 27563395
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Loss of Histone H3 K79 Methyltransferase Dot1l Facilitates Kidney Fibrosis by Upregulating Endothelin 1 through Histone Deacetylase 2.
    Zhang L; Chen L; Gao C; Chen E; Lightle AR; Foulke L; Zhao B; Higgins PJ; Zhang W
    J Am Soc Nephrol; 2020 Feb; 31(2):337-349. PubMed ID: 31843983
    [TBL] [Abstract][Full Text] [Related]  

  • 85. DOT1L regulates dystrophin expression and is critical for cardiac function.
    Nguyen AT; Xiao B; Neppl RL; Kallin EM; Li J; Chen T; Wang DZ; Xiao X; Zhang Y
    Genes Dev; 2011 Feb; 25(3):263-74. PubMed ID: 21289070
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Differentiation and localization of interneurons in the developing spinal cord depends on DOT1L expression.
    Gray de Cristoforis A; Ferrari F; Clotman F; Vogel T
    Mol Brain; 2020 May; 13(1):85. PubMed ID: 32471461
    [TBL] [Abstract][Full Text] [Related]  

  • 87. The protective role of DOT1L in UV-induced melanomagenesis.
    Zhu B; Chen S; Wang H; Yin C; Han C; Peng C; Liu Z; Wan L; Zhang X; Zhang J; Lian CG; Ma P; Xu ZX; Prince S; Wang T; Gao X; Shi Y; Liu D; Liu M; Wei W; Wei Z; Pan J; Wang Y; Xuan Z; Hess J; Hayward NK; Goding CR; Chen X; Zhou J; Cui R
    Nat Commun; 2018 Jan; 9(1):259. PubMed ID: 29343685
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Identification of DOT1L inhibitors by structure-based virtual screening adapted from a nucleoside-focused library.
    Gibbons GS; Chakraborty A; Grigsby SM; Umeano AC; Liao C; Moukha-Chafiq O; Pathak V; Mathew B; Lee YT; Dou Y; Schürer SC; Reynolds RC; Snowden TS; Nikolovska-Coleska Z
    Eur J Med Chem; 2020 Mar; 189():112023. PubMed ID: 31978781
    [TBL] [Abstract][Full Text] [Related]  

  • 89. The histone methyltransferase DOT1L is a new epigenetic regulator of pulmonary fibrosis.
    Yang D; Xu P; Su H; Zhong W; Xu J; Su Z; Liu X
    Cell Death Dis; 2022 Jan; 13(1):60. PubMed ID: 35039472
    [TBL] [Abstract][Full Text] [Related]  

  • 90. The DOT1L inhibitor Pinometostat decreases the host-response against infections: Considerations about its use in human therapy.
    Marcos-Villar L; Nieto A
    Sci Rep; 2019 Nov; 9(1):16862. PubMed ID: 31727944
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Characterization of the DOT1L network: implications of diverse roles for DOT1L.
    Park G; Gong Z; Chen J; Kim JE
    Protein J; 2010 Apr; 29(3):213-23. PubMed ID: 20431927
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Histone H3K79 methyltransferase Dot1L is directly activated by thyroid hormone receptor during Xenopus metamorphosis.
    Matsuura K; Fujimoto K; Das B; Fu L; Lu CD; Shi YB
    Cell Biosci; 2012 Jul; 2(1):25. PubMed ID: 22800560
    [TBL] [Abstract][Full Text] [Related]  

  • 93. TALEN-Mediated FLAG-Tagging of Endogenous Histone Methyltransferase DOT1L.
    An C; Zhu G; Martos SN; Feng X; Zhang H; Jia Y; Wang Z
    Adv Biosci Biotechnol; 2017 Sep; 8(9):311-323. PubMed ID: 29796335
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Histone H2B ubiquitin ligase RNF20 is required for MLL-rearranged leukemia.
    Wang E; Kawaoka S; Yu M; Shi J; Ni T; Yang W; Zhu J; Roeder RG; Vakoc CR
    Proc Natl Acad Sci U S A; 2013 Mar; 110(10):3901-6. PubMed ID: 23412334
    [TBL] [Abstract][Full Text] [Related]  

  • 95. A novel germline variant in the DOT1L gene co-segregating in a Dutch family with a history of melanoma.
    Salgado C; Kwesi-Maliepaard EM; Jochemsen AG; Visser M; Harland M; van Leeuwen F; van Doorn R; Gruis N
    Melanoma Res; 2019 Dec; 29(6):582-589. PubMed ID: 31524790
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Histone methyltransferase DOT1L controls state-specific identity during B cell differentiation.
    Aslam MA; Alemdehy MF; Kwesi-Maliepaard EM; Muhaimin FI; Caganova M; Pardieck IN; van den Brand T; van Welsem T; de Rink I; Song JY; de Wit E; Arens R; Jacobs H; van Leeuwen F
    EMBO Rep; 2021 Feb; 22(2):e51184. PubMed ID: 33410591
    [TBL] [Abstract][Full Text] [Related]  

  • 97. DOT1L inhibition is lethal for multiple myeloma due to perturbation of the endoplasmic reticulum stress pathway.
    Dafflon C; Gaulis S; Barys L; Kapur K; Cornacchione V; Schukur L; Bergling S; Traggiai E; Jansky S; Hellmann L; Engstler BS; Kerr G; de Weck A; Ruddy DA; Naumann U; Stauffer F; Gaul C; Lin Y; Billy E; Weiss A; Hofmann F; Ito M; Tiedt R
    Oncotarget; 2020 Mar; 11(11):956-968. PubMed ID: 32215184
    [TBL] [Abstract][Full Text] [Related]  

  • 98. DOT1L Activity Promotes Proliferation and Protects Cortical Neural Stem Cells from Activation of ATF4-DDIT3-Mediated ER Stress In Vitro.
    Roidl D; Hellbach N; Bovio PP; Villarreal A; Heidrich S; Nestel S; Grüning BA; Boenisch U; Vogel T
    Stem Cells; 2016 Jan; 34(1):233-45. PubMed ID: 26299268
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Nullifying epigenetic writer DOT1L attenuates neointimal hyperplasia.
    Huang Y; Urabe G; Zhang M; Li J; Ozer HG; Wang B; Kent KC; Guo LW
    Atherosclerosis; 2020 Sep; 308():22-31. PubMed ID: 32799103
    [TBL] [Abstract][Full Text] [Related]  

  • 100. An emerging maestro of immune regulation: how DOT1L orchestrates the harmonies of the immune system.
    Kealy L; Runting J; Thiele D; Scheer S
    Front Immunol; 2024; 15():1385319. PubMed ID: 38962004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.